West Pharmaceutical Services Work in process increased by 5.3% to $108.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 31.1%, from $82.90M to $108.70M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 13.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $65.80M | $71.10M | $63.50M | $70.20M | $69.00M | $79.00M | $79.00M | $95.90M | $93.80M | $93.80M | $87.30M | $81.60M | $81.10M | $80.00M | $65.20M | $82.90M | $91.10M | $97.60M | $103.20M | $108.70M |
| QoQ Change | — | +8.1% | -10.7% | +10.6% | -1.7% | +14.5% | +0.0% | +21.4% | -2.2% | +0.0% | -6.9% | -6.5% | -0.6% | -1.4% | -18.5% | +27.1% | +9.9% | +7.1% | +5.7% | +5.3% |
| YoY Change | — | — | — | — | +4.9% | +11.1% | +24.4% | +36.6% | +35.9% | +18.7% | +10.5% | -14.9% | -13.5% | -14.7% | -25.3% | +1.6% | +12.3% | +22.0% | +58.3% | +31.1% |
| % of Inventories | 19.1% | 20.1% | 16.8% | 16.9% | 16.8% | 19.1% | 19.0% | 21.5% | 20.9% | 21.7% | 20.1% | 19.0% | 19.3% | 19.9% | 17.3% | 21.3% | 21.6% | 22.3% | 23.2% | 24.0% |
| Share Change | — | +1.0pp | -3.3pp | +0.1pp | -0.1pp | +2.4pp | -0.1pp | +2.4pp | -0.6pp | +0.9pp | -1.6pp | -1.1pp | +0.4pp | +0.6pp | -2.6pp | +4.0pp | +0.3pp | +0.6pp | +1.0pp | +0.8pp |